Rakesh Eshwarlal Mutha

Dr. Rakesh Eshwarlal Mutha

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2021 in Future Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
RMRakesh Eshwarlal Mutha
Rakesh Eshwarlal Mutha
ATAnilkumar U. Tatiya
Anilkumar U. Tatiya
SSSanjay J. Surana
Sanjay J. Surana
Background: Natural plants and plant-derived formulations have been used by mankind from the ancient period of time. For the past few years, many investigations elaborated the therapeutic potential of various secondary chemicals present in the plants. Literature revealed that the various secondary metabolites, viz. phenolics and flavonoids, are responsible for a variety of therapeutic action in humans. Main body: In the present review, an attempt has been made to compile the exploration of natural phenolic compounds with major emphasis on flavonoids and their therapeutic potential too. Interestingly, long-term intake of many dietary foods (rich in phenolics) proved to be protective against the development and management of diabetes, cancer, osteoporosis, cardiovascular diseases and neurodegenerative diseases, etc. Conclusion: This review presents an overview of flavonoid compounds to use them as a potential therapeutic alternative in various diseases and disorders. In addition, the present understanding of phenolics and flavonoids will serve as the basis for the next scientific studies.

1 October 2021 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
PBPiyush S. Bafna
Piyush S. Bafna
PPPayal H. Patil
Payal H. Patil
SMSaurabh Maru
Saurabh Maru
RMRakesh Eshwarlal Mutha
Rakesh Eshwarlal Mutha

4 May 2021 in Drug Development and Industrial Pharmacy
Verified
Journal Article
Closed access
PDPrashant K. Deshmukh
Prashant K. Deshmukh
RMRakesh Eshwarlal Mutha
Rakesh Eshwarlal Mutha
SSSanjay J. Surana
Sanjay J. Surana
Chrysin (CHR), a flavone found in multiple vegetables, fruits and mushrooms has been explored so far as a neurotropic, anti-inflammatory and anti-cancer biomolecule. Despite the stated therapeutic potential, low solubility and bioavailability limit its therapeutic benefit. To circumvent these drawbacks, development of chrysin liposomes (CLPs) is reported in the present investigation. The CLPs were developed by electrostatic deposition assisted film hydration method using chitosan/lecithin to protect chrysin in the nano-lipoidal shell. Developed CLPs were extensively characterized by DSC, XPRD, FE-SEM, TEM, particle size, polydispersity index, zeta potential, percent drug loading and encapsulation efficiency. These CLPs were further characterized by in vitro dissolution, in vivo bioavailability, in vitro anticancer and stability study. Suitable particle size, PDI and ZP implying stabilization of developed CLPs. The % DL and % EE was found to be 3.56 ± 0.13 and 90.5 ± 1.49 respectively. DSC and PXRD study revealed amorphous transition of CHR, which may help to increase its solubility and dissolution profile. In vivo pharmacokinetic study demonstrated more than 5-fold increase in relative bioavailability of CLPs. The in silico molecular docking study results demonstrated the electrostatic interaction between two polymers. The present study suggests that chitosan could protect and encapsulate chrysin which eventually enhances its cytotoxicity as well as bioavailability.

15 March 2013 in Journal of Biological Sciences
Verified
Journal Article
Closed access
ATAnil U. Tatiya
Anil U. Tatiya
PDPayal R. Dande
Payal R. Dande
RMRakesh Eshwarlal Mutha
Rakesh Eshwarlal Mutha
SSSanjay J. Surana
Sanjay J. Surana

17 April 2018 in Materials Technology
Verified
Journal Article
Closed access
RMRakesh Eshwarlal Mutha
Rakesh Eshwarlal Mutha
SSSanjay J. Surana
Sanjay J. Surana
In present investigation, we are the first to report ultrasonic frequency based development of chrysin nanoparticles (CNPs) with special emphasis on bioavailability, anti-cancer activity and stability assessment. The CNPs were developed by modifying processing parameters to get an optimum nanonization effect. Chrysin (CHR), being a member of flavonoid class, has a strong proven therapeutic value but poor solubility and bioavailability restrict its use as a therapeutic agent. Developed CNPs were evaluated for various physicochemical and performance characteristics like DSC, XRPD, FE-SEM, TEM, particle size, polydispersity index (PDI), zeta potential, production yield, solubility, in vitro dissolution, in vivo bioavailability and stability study. Oral bioavailability study revealed 2·3-fold increase in relative bioavailability of CNPs compared to pure CHR. In vitro cytotoxicity study demonstrated promising cytotoxic effect towards MCF-7 human breast cancer cell line. Developed CNPs demonstrated acceptable particle size and zeta potential indicating significant stability, which was further confirmed by stability assessment. The present study suggests that natural flavonoids like CHR could demonstrate potential cytotoxicity when subjected to nanonization and may prove beneficial as a natural economic alternative to expensive chemotherapy in near future.

13 May 2013 in Bangladesh Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
ATAnil U. Tatiya
Anil U. Tatiya
PPPallavi M. Puranik
Pallavi M. Puranik
SSSanjay J. Surana
Sanjay J. Surana
YPYogesh S. Patil
Yogesh S. Patil
RMRakesh Eshwarlal Mutha
Rakesh Eshwarlal Mutha
The tuber of Eulophia herbacea is widely used in the treatment of obesity in traditional medicine. Methanolic extract, aqueous extract and isolated gluco-mannan were tested for triton WR-1339 induced hyperlipidemia and alloxan-induced diabetes in rats. Blood samples were collected and analysed for lipid profile and blood glucose. Glucomannan was isolated and characterised. Antioxidant activity of test sample was determined by superoxide radical and lipid peroxidation assay and compared it with standards ascorbic acid. The findings showed that folk medicinal claim of E. herbacea tubers possess hypolipidemic, hypoglycemic and antioxidant effects. DOI: http://dx.doi.org/10.3329/bjp.v8i3.14880 Bangladesh Journal of Pharmacology Vol.8(3) 2013 269-275